A Phase 2, Open-label, Randomized, Two-stage Clinical Studyof Alvocidib in Patients with Relapsed/Refractory AcuteMyeloid Leukemia Following Treatment with VenetoclaxCombination Therapy

  • Warlick, Erica D (PI)

Project: Research project

Project Details

Description

A Phase 2, Open-label, Randomized, Two-stage Clinical Study of Alvocidib in Patients with Relapsed/Refractory Acute Myeloid Leukemia Following Treatment with Venetoclax Combination Therapy
StatusActive
Effective start/end date3/1/20 → 2/28/25

Funding

  • TOLERO PHARMACEUTICALS, INC.

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
View full fingerprint